Hodgkin-Lymphom (Morbus Hodgkin) - Kinderkrebsstiftung

Hodgkin-Lymphom (Morbus Hodgkin) Seite 62
on tomography (FDG-PET) for staging and therapy control of Hodgkin's lymphoma in
childhood and adolescence - consequences for the GPOH-HD 2003 protocol“, Onkologie
2003 ;26(5):489-93, 14605468 pubmed
[14] Uppenkamp M, Feller AC „Classification of malignant lymphoma“, Onkologie 2002,25:563-570,
12566903 pubmed
[15] Jaffe ES et al. „World Health Organization classification of tumours. Pathology and genetics of
tumours of hematopoietic and lymphoid tissues“, IARC Press, Lyon 2001
[16] Bennett MH, MacLennan KA, Easterling MJ, Vaughan Hudson B, Vaughan Hudson G, Jelliffe
AM „Analysis of histological subtypes in Hodgkin’s disease in relation to prognosis and survival,
in Quaglino D, Hayhoe FGJ (eds.): The cytobiology of leukaemias and lymphomas.“,
Serono symposia publications from Raven press, New York 1985
[17] Mauz-Körholz C,Gorde-Grosjean S,Hasenclever D,Shankar A,Dörffel W,Wallace
WH,Schellong G,Robert A,Körholz D,Oberlin O,Hall GW,Landman-Parker J „Resection alone
in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience
from the European network group on pediatric Hodgkin lymphoma.“, Cancer 2007
1;110(1):179-85, 17526010 pubmed
[18] Hudson MM, Poquette CA, Lee J, Greenwald CA, Shah A, Luo X, Thompson EI, Wilimas JA,
Kun LE, Crist WM „Increased mortality after successful treatment for Hodgkin's disease“,
J Clin Oncol 1998,16:3592, 9817280 pubmed
[19] Rühl U, Albrecht M, Dieckmann K, Lüders H, Marciniak H, Schellenberg D, Wickmann L, Dörffel
W „Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease“, Int J
Radiation Oncology Biol Phys 2001,51:1209-1218, 11728679 pubmed
[20] Klingebiel T „Knochenmark- und Stammzelltransplantation, in Gutjahr P: Krebs bei Kindern und
Jugendlichen.“, Deutscher Ärzte-Verlag Köln 5. Aufl. 2004:83, 3769104285 isbn
[21] Urbano-Ispizua A, Schmitz N, de Witte T et al; European Group for Blood and Marrow Transplantation
„Allogeneic and autologous transplantation for haematological diseases, solid
tumours and immune disorders: definitions and current practice in Europe“, Bone Marrow
Transplant 2002,29:639-646, 12180107 pubmed
[22] Schellong G, Riepenhausen M „Spätfolgen nach Hodgkinscher Krankheit“,
WIR 2003,1:18-24, http://www.kinderkrebsstiftung.de/fileadmin/KKS/files/zeitschrift-
WIR/2003_1/hodgkinscheKrankheit.pdf uri
[23] Schellong G,Dorffel W,Claviez A,Korholz D,Mann G,Scheel-Walter HG,Bokkerink
JP,Riepenhausen M,Luders H,Potter R,Ruhl U,DAL/GPOH „Salvage therapy of progressive
and recurrent Hodgkin's disease: results from a multicenter study of the pediatric
DAL/GPOH-HD study group.“, Journal of clinical oncology 2005 ;23(25):6181-9, 16135485
pubmed